News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
275,667 Results
Type
Article (14547)
Company Profile (107)
Press Release (261005)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (88834)
Career Advice (481)
Deals (15556)
Drug Delivery (73)
Drug Development (36919)
Employer Resources (52)
FDA (6447)
Job Trends (6470)
News (151733)
Policy (14242)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (447)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23388)
ALS (56)
Alzheimer's disease (481)
Antibody-drug conjugate (ADC) (106)
Approvals (6644)
Artificial intelligence (201)
Autoimmune disease (41)
Automation (12)
Bankruptcy (150)
Best Places to Work (4611)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1335)
Cardiovascular disease (151)
Career advice (429)
Career pathing (13)
CAR-T (49)
CDC (6)
Cell therapy (151)
Cervical cancer (9)
Clinical research (32203)
Collaboration (731)
Compensation (325)
Complete response letters (33)
COVID-19 (780)
CRISPR (43)
C-suite (438)
Cystic fibrosis (58)
Data (1842)
Denatured (18)
Depression (47)
Diabetes (126)
Diagnostics (1383)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (114)
Drug pricing (115)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33706)
Editorial (21)
Employer branding (5)
Employer resources (47)
Events (39241)
Executive appointments (533)
FDA (7559)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (429)
Gene editing (70)
Generative AI (18)
Gene therapy (165)
GLP-1 (439)
Government (1423)
Grass and pollen (4)
Guidances (164)
Healthcare (3600)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (54)
Infectious disease (845)
Inflammatory bowel disease (76)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (113)
Interviews (63)
IPO (5964)
IRA (33)
Job creations (2083)
Job search strategy (385)
JPM (30)
Kidney cancer (9)
Labor market (28)
Layoffs (209)
Leadership (8)
Legal (3485)
Liver cancer (22)
Longevity (8)
Lung cancer (185)
Lymphoma (130)
Machine learning (13)
Management (17)
Manufacturing (413)
MASH (67)
Medical device (1321)
Medtech (1328)
Mergers & acquisitions (10021)
Metabolic disorders (435)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (83)
Neuropsychiatric disorders (37)
Neuroscience (898)
Neurotech (1)
NextGen: Class of 2026 (1608)
Non-profit (602)
Now hiring (17)
Obesity (228)
Opinion (145)
Ovarian cancer (43)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (84)
Partnered (11)
Patents (221)
Patient recruitment (116)
Peanut (12)
People (29962)
Pharmaceutical (64)
Pharmacy benefit managers (18)
Phase 1 (8315)
Phase 2 (13593)
Phase 3 (12326)
Pipeline (1922)
Policy (135)
Postmarket research (1405)
Preclinical (3350)
Press Release (25)
Prostate cancer (85)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (350)
Real estate (2677)
Recruiting (20)
Regulatory (11032)
Reports (15)
Research institute (576)
Resumes & cover letters (58)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (72)
Series A (81)
Series B (48)
Service/supplier (2)
Sickle cell disease (46)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1657)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (231)
Venture capital (33)
Weight loss (140)
Women's health (27)
Worklife (4)
Date
Last 7 days (178)
Last 30 days (679)
Last 365 days (10488)
2026 (960)
2025 (10797)
2024 (12602)
2023 (14362)
2022 (19794)
2021 (20337)
2020 (19267)
2019 (14997)
2018 (11791)
2017 (14002)
2016 (13235)
2015 (15522)
2014 (12462)
2013 (10626)
2012 (11429)
2011 (11947)
2010 (10926)
Location
Africa (326)
Alabama (19)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20977)
Australia (2697)
California (3195)
Canada (1493)
China (551)
Colorado (144)
Connecticut (130)
Delaware (123)
Europe (41079)
Florida (601)
Georgia (63)
Hawaii (1)
Idaho (10)
Illinois (432)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (422)
Massachusetts (2594)
Michigan (46)
Minnesota (165)
Mississippi (1)
Missouri (33)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1396)
New Mexico (7)
New York (907)
North Carolina (619)
North Dakota (2)
Northern California (1450)
Ohio (80)
Oklahoma (5)
Oregon (18)
Pennsylvania (715)
Puerto Rico (12)
Rhode Island (17)
South America (516)
South Carolina (10)
Southern California (1399)
Tennessee (54)
Texas (455)
United States (12777)
Utah (59)
Virginia (160)
Washington D.C. (43)
Washington State (223)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
275,667 Results for "allergan pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Allergan Aesthetics Unveils New Data Across Facial Injectables On-Market and Emerging Portfolio at IMCAS 2026 Showcasing Enduring Strength in Advancing Aesthetics Medicine
January 29, 2026
·
18 min read
Press Releases
Allergan Aesthetics Unveils New Data at 2025 American Society for Dermatologic Surgery Annual Meeting Showcasing Transformative Innovation and Portfolio Excellence
November 13, 2025
·
17 min read
Press Releases
Allergan Aesthetics to Showcase Multimodal Treatment Approach and Continued Commitment to Skin Quality at AMWC Dubai
September 25, 2025
·
9 min read
Press Releases
Allergan Aesthetics Announces Expansion of SKINVIVE by JUVÉDERM® into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality
September 23, 2025
·
7 min read
Layoffs
AbbVie’s Allergan Cuts Over 200 Staff After Botched Marketing Campaign
The layoffs will take effect on July 22 and particularly target those working in sales, data engineering and product management.
May 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
U.S. Food and Drug Administration Accepts for Review Allergan Aesthetics Premarket Approval Application for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
June 30, 2025
·
16 min read
Press Releases
Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025
March 24, 2025
·
10 min read
Business
Allergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-Ups
University Lab Partners (ULP) is thrilled to announce the return of the Golden Ticket pitch competition for aesthetic startups, proudly sponsored by Allergan Aesthetics, an AbbVie Company.
April 12, 2024
·
2 min read
Press Releases
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
January 24, 2025
·
10 min read
Press Releases
Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans
January 29, 2025
·
7 min read
1 of 27,567
Next
